NCT02968277

Brief Summary

The purpose of this project is to evaluate if the LifeWalker Upright walker is improves walking and reports of pain compared to a conventional rollator and predicate walker device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 25, 2016

Completed
24 days until next milestone

First Posted

Study publicly available on registry

November 18, 2016

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
5 months until next milestone

Results Posted

Study results publicly available

September 6, 2019

Completed
Last Updated

September 6, 2019

Status Verified

August 1, 2019

Enrollment Period

2.8 years

First QC Date

October 25, 2016

Results QC Date

May 22, 2019

Last Update Submit

August 15, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • 6 Minute Walk Test

    The 6 minute walk test is performed as an objective evaluation of functional exercise capacity. The 6minute walk test is easy to administer, well tolerated, and typically reflective of activities of daily living. The test measures the distance that the patient can walk on a flat, hard surface, indoors, in a period of 6 minutes. The walk test is patient self-paced and assesses the level of functional capacity. Patients are allowed to stop and rest during the test, however, the timer does not stop. If the patient is unable to complete the time, the time stopped is noted and reason for stopping prematurely is recorded. The number of stops and stumbles will be recorded during the test. This test will be administered while wearing a mask to measure oxygen consumption in addition to blood pressure, heart rate and oxygen saturation.

    One testing session

Secondary Outcomes (6)

  • 10 Meter Walk Test

    One testing session

  • Baseline Modified Falls Efficacy Scale (mFES) Score:

    Baseline score taken at first session

  • Visual Analog Pain Scale (VAS)

    Baseline score taken at first session

  • User Functional Rating Scale

    One testing session

  • Borg Rate of Perceived Exertion

    One testing session

  • +1 more secondary outcomes

Study Arms (3)

Started with Forearm Support Walker (LW Upright)

EXPERIMENTAL

Data collection began with participants using the LifeWalker Upright Walker then using the two remaining walkers in a randomized order

Device: LifeWalker UprightDevice: Predicate DeviceDevice: Standard Rollator

Standard Rollator Walker (Control)

EXPERIMENTAL

Data collection began with participants using a conventional standard rollator (SR) walker then using the two remaining walkers in a randomized order

Device: LifeWalker UprightDevice: Predicate DeviceDevice: Standard Rollator

Predicate Device (PD)

EXPERIMENTAL

Data collection began with participants using their own rollator walkers then using the two remaining walkers in a randomized order

Device: LifeWalker UprightDevice: Predicate DeviceDevice: Standard Rollator

Interventions

LifeWalker (LW) upright walker

Predicate Device (PD)Standard Rollator Walker (Control)Started with Forearm Support Walker (LW Upright)

Individual's personal walker

Predicate Device (PD)Standard Rollator Walker (Control)Started with Forearm Support Walker (LW Upright)

A control rollator device

Predicate Device (PD)Standard Rollator Walker (Control)Started with Forearm Support Walker (LW Upright)

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals who use a walker due to back pain or adults (over 18) who use a walker for ambulation.
  • Ages from 18 to 89 years old
  • Medically stable for therapy

You may not qualify if:

  • Patient weight exceeds 300 lbs
  • Patient height is below 5'0" or exceeds 6'3"
  • Inactive, physically unfit to fit into the device.
  • Cognitive deficits or visual impairment that would impair their ability to give informed consent or to follow simple instructions during the experiments.
  • Mini-Mental State Exam (MMSE) score below 17
  • Pregnant women
  • Co-morbidity that interferes with the study (e.g. stroke, pace maker placement, severe ischemia cardiac disease, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation Institute of Chicago

Chicago, Illinois, 60611, United States

Location

Related Publications (1)

  • Jayaraman C, Mummidisetty CK, Loesch A, Kaur S, Hoppe-Ludwig S, Staat M, Jayaraman A. Postural and Metabolic Benefits of Using a Forearm Support Walker in Older Adults With Impairments. Arch Phys Med Rehabil. 2019 Apr;100(4):638-647. doi: 10.1016/j.apmr.2018.10.001. Epub 2018 Oct 24.

MeSH Terms

Conditions

Back Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

All assessments were done on level ground surfaces, all tests were done in controlled, clinical environment. Long term effects of using LifeWalker could not be determined in this study. The pathological demographic of the study sample was diverse.

Results Point of Contact

Title
Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes
Organization
Rehabilitation Institute of Chicago

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: No washout period between different arms
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 25, 2016

First Posted

November 18, 2016

Study Start

June 1, 2016

Primary Completion

April 1, 2019

Study Completion

April 1, 2019

Last Updated

September 6, 2019

Results First Posted

September 6, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations